Skip to main content

Want a detailed portfolio tracker?

Telix Pharmaceuticals (TLX) P/E (2024 - 2026)

Telix Pharmaceuticals (TLX) P/E from Nov 14, 2024 to Jun 3, 2026. The TTM Telix Pharmaceuticals (TLX) P/E is -614.22. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Telix Pharmaceuticals (TLX)

YearP/EChange
2026-614.22+17.09%
2025-524.57-333.46%
2024224.70N/A

Comparison Telix Pharmaceuticals (TLX) P/E with competitors

Telix Pharmaceuticals (TLX) P/E is -614.22.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.00%
NBYStablecoin Development Corp0.10-100.02%
ENLVEnlivex Therapeutics Ltd0.15-100.02%
FGENFibroGen Inc0.24-100.04%
TRAWTraws Pharma Inc0.47-100.08%
FBIOFortress Biotech Inc0.71-100.11%
CHRSCoherus Biosciences Inc0.98-100.16%
ORMPOramed Pharmaceuticals Inc1.47-100.24%
AGENAgenus Inc2.05-100.33%
VIVSVivoSim Labs Inc2.54-100.41%
INVAInnoviva Inc3.19-100.52%
CRMDCorMedix Inc3.65-100.59%
ABEOAbeona Therapeutics Inc4.20-100.68%
VXRTVaxart Inc4.26-100.69%
CVACCureVac N.V.4.45-100.72%
SRPTSarepta Therapeutics Inc4.62-100.75%
GLPGGalapagos NV4.86-100.79%
RIGLRigel Pharmaceuticals4.92-100.80%
ZVRAZevra Therapeutics Inc4.97-100.81%
ABUSArbutus Biopharma Corp5.69-100.93%
CGENCompugen Ltd7.38-101.20%
AUPHAurinia Pharmaceuticals Inc9.25-101.51%
ACADAcadia Pharmaceuticals Inc9.59-101.56%
OMEROmeros Corporation9.88-101.61%
PLXProtalix BioTherapeutics Inc9.91-101.61%
SPROSpero Therapeutics Inc10.73-101.75%
ADMAAdma Biologics Inc11.33-101.84%
SVASinovac Biotech Ltd11.44-101.86%
TBPHTheravance Biopharma Inc11.78-101.92%
HRMYHarmony Biosciences Holdings Inc12.18-101.98%
TGTXTG Therapeutics Inc13.18-102.15%
INCYIncyte Corp13.38-102.18%
SABSSAB Biotherapeutics Inc14.06-102.29%
XOMAXOMA Corp14.95-102.43%
REGNRegeneron Pharmaceuticals Inc14.98-102.44%
PBYIPuma Biotechnology Inc15.05-102.45%
EXELExelixis Inc15.79-102.57%
NAGENiagen Bioscience Inc16.35-102.66%
CPRXCatalyst Pharmaceuticals Inc17.34-102.82%
MDXGMimedx Group Inc17.38-102.83%
ARGXArgen X SE23.07-103.76%
HALOHalozyme Therapeutics Inc23.20-103.78%
XOMAOXOMA Corp25.34-104.13%
VRTXVertex Pharmaceuticals Inc25.66-104.18%
XOMAPXOMA Corp25.67-104.18%
CTMXCytomX Therapeutics Inc25.70-104.18%
ASNDAscendis Pharma A/S26.35-104.29%
RPRXRoyalty Pharma plc - Class A27.50-104.48%
SLNOSoleno Therapeutics Inc29.02-104.72%
LGNDLigand Pharmaceuticals Inc - Class B30.19-104.91%
BMRNBiomarin Pharmaceutical Inc37.51-106.11%
APLSApellis Pharmaceuticals Inc39.02-106.35%
KRYSKrystal Biotech Inc39.70-106.46%
GMABGenmab40.20-106.55%
ONCBeiGene Ltd67.03-110.91%
TECHBio-Techne Corp68.59-111.17%
VCELVericel Corp80.63-113.13%
PHARPharming Group N.V.87.74-114.28%
ALNYAlnylam Pharmaceuticals Inc124.93-120.34%
CORTCorcept Therapeutics Inc158.39-125.79%